Transgenomics — Omaha, Nebraska

Transgenomics is a clinical research site located in Omaha, Nebraska, United States 68164.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Transgenomics has participated in 2 clinical trials.

Therapeutic areas: Uterine Cervical Neoplasm, Uterine Cervical Neoplasms.

Sponsors: Becton, Dickinson and Company.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Transgenomics?

Transgenomics has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Transgenomics conducted?

Transgenomics has 2 clinical trials on record. Their work covers Uterine Cervical Neoplasm, Uterine Cervical Neoplasms.

Is Transgenomics accredited by Crixeo Health?

Transgenomics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Transgenomics?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.